4//SEC Filing
ROWLAND LLOYD A 4
Accession 0001610717-25-000083
CIK 0001501989other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 4:32 PM ET
Size
4.6 KB
Accession
0001610717-25-000083
Insider Transaction Report
Form 4
ROWLAND LLOYD A
General Counsel
Transactions
- Sale
Common Stock
2025-03-18$0.60/sh−10,203$6,112→ 120,594 total
Footnotes (2)
- [F1]The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units ("RSUs").
- [F2]Includes 30,624 RSUs.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeother
Related Parties
1- filerCIK 0001236395
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 4:32 PM ET
- Size
- 4.6 KB